Amended in Senate March 11, 2014

Amended in Senate January 7, 2014

Amended in Senate September 6, 2013

Amended in Senate August 19, 2013

Amended in Senate August 12, 2013

Amended in Assembly April 11, 2013

Amended in Assembly March 19, 2013

California Legislature—2013–14 Regular Session

Assembly BillNo. 467


Introduced by Assembly Member Stone

(Principal coauthor: Senator Hill)

February 19, 2013


An act to add Section 4046 to, and to add Article 11.5 (commencing with Section 4169.5) to Chapter 9 of Division 2 of, the Business and Professions Code, and to amend Sections 150201, 150202, and 150205 of, and to add Section 150208 to, the Health and Safety Code, relating to pharmaceuticals, making an appropriation therefor, and declaring the urgency thereof, to take effect immediately.

LEGISLATIVE COUNSEL’S DIGEST

AB 467, as amended, Stone. Prescription drugs: collection and distribution program.

Existing law authorizes a county to establish, by ordinance, a repository and distribution program under which specified pharmacies and primary care clinics may distribute surplus unused medications, as defined, to persons in need of financial assistance to ensure access to necessary pharmaceutical therapies. Existing law authorizes specified health and care facilities, pharmacies, drug manufacturers, and pharmacy wholesalers to donate unused medications to the program. Existing law requires a county that has established a program to establish procedures to, among other things, ensure proper safety and management of any medications collected and maintained by a participating entity. Existing law exempts specified persons and entities, including prescription drug manufacturers and pharmacists and physicians who accept or dispense prescription drugs, from criminal and civil liability for injury caused when donating, accepting, or dispensing prescription drugs in compliance with these provisions.

Existing law, the Pharmacy Law, governs the scope and practice of pharmacy, including dispensing dangerous drugs and devices. Existing law establishes in the Department of Consumer Affairs the California State Board of Pharmacy to exercise licensing, regulatory, and disciplinary functions with respect to the practice of pharmacy. Existing law provides that fees collected on behalf of the board are credited to the Pharmacy Board Contingent Fund, a continuously appropriated fund. A violation of the Pharmacy Law is a crime.

This bill would require the California State Board of Pharmacy to license a surplus medication collection and distribution intermediary, as defined, established for the purpose of facilitating the donation of medications to or transfer of medications between participating entities under the unused medication repository and distribution program described above. Among other things, the bill would prohibit that intermediary from taking possession, custody, or control of dangerous drugs and devices, but would authorize the intermediary to charge specified fees for the reasonable costs of the support and services provided. The bill would also require a surplus medication collection and distribution intermediary to keep and maintain for 3 years complete records for which the intermediary facilitated the donation of medications to or transfer of medications between participating entities. The bill would require that a surplus medication collection and distribution intermediarybegin delete be licensed by the board, as specified, would require that theend delete license be renewed annually, and would require the payment of a fee in the amount of $300 to obtain or renew the license. The bill would provide that the fees collected would be deposited in the Pharmacy Board Contingent Fund. By providing a new source of funds for a continuously appropriated fund, the bill would make an appropriation. Because a violation of the provisions governing licensing andbegin delete record-keepingend deletebegin insert recordkeepingend insert would be crimes, the bill would impose a state-mandated local program. The bill would exempt a surplus medication collection and distribution intermediary from criminal or civil liability for injury caused when facilitating the donation of medications to or transfer of medications in compliance with these provisions.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason.

This bill would declare that it is to take effect immediately as an urgency statute.

Vote: 23. Appropriation: yes. Fiscal committee: yes. State-mandated local program: yes.

The people of the State of California do enact as follows:

P3    1

SECTION 1.  

Section 4046 is added to the Business and
2Professions Code
, to read:

3

4046.  

“Surplus medication collection and distribution
4intermediary” means a firm, association, partnership, corporation,
5limited liability company, state governmental agency, or political
6subdivision that performs the functions specified in Section 4169.5
7for the purpose of a program established pursuant to Division 116
8(commencing with Section 150200) of the Health and Safety Code.

9

SEC. 2.  

Article 11.5 (commencing with Section 4169.5) is
10added to Chapter 9 of Division 2 of the Business and Professions
11Code
, to read:

12 

13Article 11.5.  Surplus Medication Collection and Distribution
14Intermediaries
15

 

16

4169.5.  

(a) A surplus medication collection and distribution
17intermediary established for the purpose of facilitating the donation
18of medications to or transfer of medications between participating
19entities under a program established pursuant to Division 116
20(commencing with Section 150200) of the Health and Safety Code
21shall be licensed by the board. The board shall enforce the
P4    1requirements set forth in Section 150208 of the Health and Safety
2Code. The license shall be renewed annually.

3(b) An application for licensure as a surplus medication
4collection and distribution intermediary shall be made on a form
5furnished by the board, and shall state the name, address, usual
6occupation, and professional qualifications, if any, of the applicant.
7If the applicant is an entity other than a natural person, the
8application shall state the information as to each person beneficially
9interested in that entity.

10(c) As used in this section, and subject to subdivision (e), the
11term “person beneficially interested” means and includes:

12(1) If the applicant is a partnership or other unincorporated
13association, each partner or member.

14(2) If the applicant is a corporation, each of its officers, directors,
15and stockholders, provided that no natural person shall be deemed
16to be beneficially interested in a nonprofit corporation.

17(3) If the applicant is a limited liability company, each officer,
18manager, or member.

19(d) If the applicant is a charitable organization described in
20Section 501(c)(3) of the Internal Revenue Code, the applicant shall
21furnish the board with the organization’s articles of incorporation.
22The applicant shall also furnish the board with the names of the
23controlling members.

24(e) If the applicant is a partnership or other unincorporated
25association, a limited liability company, or a corporation, and if
26the number of partners, members, or stockholders, as the case may
27be, exceeds five, the application shall so state, and shall further
28state the information required by subdivisionbegin delete (a)end deletebegin insert (b)end insert as to each of
29the five partners, members, or stockholders who own the five
30largest interests in the applicant’s entity. Upon request by the
31executive officer of the board, the applicant shall furnish the board
32with the information required by subdivisionbegin delete (a)end deletebegin insert (b)end insert as to partners,
33members, or stockholders not named in the application, or shall
34refer the board to an appropriate source of that information.

35(f) The application shall contain a statement to the effect that
36the applicant or persons beneficially interested have not been
37convicted of a felony and have not violated any of the provisions
38of this chapter. If the applicant cannot make this statement, the
39application shall contain a statement of the violation, if any, or
P5    1reasons which will prevent the applicant from being able to comply
2with the requirements with respect to the statement.

3(g) Upon the approval of the application by the board and
4payment of a fee in the amount of three hundred dollars ($300),
5the executive officer of the board shall issue or renew a license to
6operate as a surplus medication collection and distribution
7intermediary, if all of the provisions of this chapter have been
8complied with. Fees received by the board pursuant to this section
9shall be deposited into the Pharmacy Board Contingent Fund. An
10applicant for licensure as a surplus medication collection and
11distribution intermediary that is government owned or is a nonprofit
12organization pursuant to subdivision (d) is exempt from the fee
13requirement.

14(h) A surplus medication collection and distribution intermediary
15licensed pursuant to this section is exempt from licensure as a
16wholesaler.

17(i) A surplus medication collection and distribution intermediary
18licensed pursuant to this section shall keep and maintain for three
19years complete records for which the intermediary facilitated the
20donation of medications to or transfer of medications between
21participating entities.

22

SEC. 3.  

Section 150201 of the Health and Safety Code is
23amended to read:

24

150201.  

For purposes of this division:

25(a) “Donor organization” means an entity described in
26subdivision (a) of Section 150202.

27(b) “Eligible entity” means all of the following:

28(1) A licensed pharmacy, as defined in subdivision (a) of Section
294037 of the Business and Professions Code, that is county owned
30or that contracts with the county pursuant to this division and is
31not on probation with the California State Board of Pharmacy.

32(2) A licensed pharmacy, as defined in subdivision (a) of Section
334037 of the Business and Professions Code, that is owned and
34operated by a primary care clinic, as defined in Section 1204, that
35is licensed by the State Department of Public Health and is not on
36probation with the California State Board of Pharmacy.

37(3) A primary care clinic, as defined in Section 1204, that is
38licensed by the State Department of Public Health and licensed to
39administer and dispense drugs pursuant to subparagraph (A) of
40paragraph (1) of subdivision (a) of Section 4180 of the Business
P6    1and Professions Code and is not on probation with the California
2State Board of Pharmacy.

3(c) “Medication” or “medications” means a dangerous drug, as
4defined in Section 4022 of the Business and Professions Code.

5(d) “Participating entity” means an eligible entity that has
6received written or electronic documentation from the county
7health department pursuant to paragraph (3) of subdivision (a) of
8Section 150204 and that operates a repository and distribution
9program pursuant to this division.

10

SEC. 4.  

Section 150202 of the Health and Safety Code is
11amended to read:

12

150202.  

(a) Notwithstanding any other law, a donor
13organization is defined, for purposes of this division, to refer to
14one of the following health and care facilities that may donate
15centrally stored unused medications under a program established
16pursuant to this division:

17(1) A licensed general acute care hospital, as defined in Section
181250.

19(2) A licensed acute psychiatric hospital, as defined in Section
201250.

21(3) A licensed skilled nursing facility, as defined in Section
221250, including a skilled nursing facility designated as an
23institution for mental disease.

24(4) A licensed intermediate care facility, as defined in Section
251250.

26(5) A licensed intermediate care facility/developmentally
27disabled-habilitative facility, as defined in Section 1250.

28(6) A licensed intermediate care facility/developmentally
29disabled-nursing facility, as defined in Section 1250.

30(7) A licensed correctional treatment center, as defined in
31Section 1250.

32(8) A licensed psychiatric health facility, as defined in Section
331250.2.

34(9) A licensed chemical dependency recovery hospital, as
35defined in Section 1250.3.

36(10) A licensed residential care facility for the elderly, as defined
37in Section 1569.2, with 16 or more residents.

38(11) An approved mental health rehabilitation center, as
39described in Section 5675 of the Welfare and Institutions Code.

P7    1(b) Medication donated by health and care facilities pursuant
2to subdivision (a) shall meet the requirements of subdivisions (c)
3and (d) of Section 150204 and shall be unexpired medication that
4would have otherwise been destroyed by the facility or another
5appropriate entity.

6(c) Medication eligible for donation by the health and care
7facilities pursuant to subdivision (a) shall be directly delivered
8from the dispensing pharmacy, wholesaler or manufacturer, to the
9health or care facility and subsequently centrally stored. Centrally
10stored medication that originated from a patient or resident is not
11eligible for donation under this division.

12

SEC. 5.  

Section 150205 of the Health and Safety Code is
13amended to read:

14

150205.  

(a) The following persons and entities shall not be
15subject to criminal or civil liability for injury caused when
16donating, accepting, or dispensing prescription drugs in compliance
17with this division:

18(1) A prescription drug manufacturer, wholesaler, governmental
19entity, or participating entity.

20(2) A pharmacist or physician who accepts or dispenses
21prescription drugs.

22(3) A licensed health or care facility, as described in Section
23150202, or a pharmacy, as described in Section 150202.5.

24(b) A surplus medication collection and distribution
25intermediary, as described in Section 150208, shall not be subject
26to criminal or civil liability for injury caused when facilitating the
27donation of medications to or transfer of medications in compliance
28with this division.

29

SEC. 6.  

Section 150208 is added to the Health and Safety Code,
30to read:

31

150208.  

(a) A surplus medication collection and distribution
32intermediary that is licensed pursuant to Section 4169.5 of the
33Business and Professions Code, established for the purpose of
34facilitating the donation of medications to or transfer of
35medications between participating entities under a program
36established pursuant to this division is authorized to operate under
37this section.

38(b) A surplus medication collection and distribution intermediary
39shall comply with the following:

P8    1(1) It shall not take possession, custody, or control of dangerous
2drugs and devices.

3(2) It shall ensure that notification is provided to participating
4entities that a package has been shipped when the surplus
5medication collection and distribution intermediary has knowledge
6of the shipment and provided logistical support to facilitate a
7shipment directly from a donor organization, as defined in
8subdivision (a) of Section 150202, to a participating entity.

9(3) It shall not select, or direct a donor organization, as defined
10in subdivision (a) of Section 150202, to select, a specific
11participating entity to receive surplus medications.

12(c) A surplus medication collection and distribution intermediary
13is authorized to do the following:

14(1) Charge membership, administrative, or overhead fees
15sufficient to cover the reasonable costs of the support and services
16provided.

17(2) Contract directly with a county to facilitate the donation of
18medications to or transfer of medications between participating
19entities and provide general support in a county’s implementation
20of a program established pursuant to this division.

21(d) No participating entities shall receive donated medication
22directly from the surplus medication collection and distribution
23intermediary.

24

SEC. 7.  

No reimbursement is required by this act pursuant to
25Section 6 of Article XIII B of the California Constitution because
26the only costs that may be incurred by a local agency or school
27district will be incurred because this act creates a new crime or
28infraction, eliminates a crime or infraction, or changes the penalty
29for a crime or infraction, within the meaning of Section 17556 of
30the Government Code, or changes the definition of a crime within
31the meaning of Section 6 of Article XIII B of the California
32Constitution.

33

SEC. 8.  

This act is an urgency statute necessary for the
34immediate preservation of the public peace, health, or safety within
35the meaning of Article IV of the Constitution and shall go into
36immediate effect. The facts constituting the necessity are:

37To ensure that California’s medication donation program is
38allowed to continue to operate to facilitate the distribution of
39medications to the indigent population which would not otherwise
P9    1have access to these medications, it is necessary that this act take
2effect immediately.



O

    92